Compound Detail
CHEMBL30022
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL30022 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VWPPUIVJOSQTOP-SAPNQHFASA-N |
5
Targets
5
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
291.4
MW (Da)
4.36
ALogP
2
HBA
0
HBD
20.3
PSA (Ų)
0.61
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 5.73
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| L1210 | IC50 | = | 1870.0 | nM | 5.73 | Inhibitory activity was tested against L1210 cells | 10212121 |
| P388 | IC50 | = | 1900.0 | nM | 5.72 | Inhibitory activity was tested against P388 cells | 10212121 |
| Jurkat | IC50 | = | 2530.0 | nM | 5.6 | Inhibitory concentration against Human Jurkat T cells | 10212121 |
| CCRF-CEM | IC50 | = | 3050.0 | nM | 5.52 | Inhibitory activity was tested against CEM cells | 10212121 |
| MOLT-4 | IC50 | = | 5250.0 | nM | 5.28 | Inhibitory activity was tested against Molt4/C8 cells | 10212121 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 10212121 | 10.1021/jm9806695 | Jurkat | 4 |
| 10212121 | 10.1021/jm9806695 | P388 | 2 |
| 10212121 | 10.1021/jm9806695 | L1210 | 2 |
| 10212121 | 10.1021/jm9806695 | MOLT-4 | 2 |
| 10212121 | 10.1021/jm9806695 | CCRF-CEM | 2 |
| 10212121 | 10.1021/jm9806695 | Tumor Cell line | 1 |
Data from ChEMBL 36 via Core Engine